• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳酸菌、益生元及其发酵产物对特定诱变剂的抗遗传毒性活性。

Antigenotoxic activity of lactic acid bacteria, prebiotics, and products of their fermentation against selected mutagens.

作者信息

Nowak Adriana, Śliżewska Katarzyna, Otlewska Anna

机构信息

Institute of Fermentation Technology and Microbiology, Lodz University of Technology, Wolczanska 171/173, 90-924 Lodz, Poland.

Institute of Fermentation Technology and Microbiology, Lodz University of Technology, Wolczanska 171/173, 90-924 Lodz, Poland.

出版信息

Regul Toxicol Pharmacol. 2015 Dec;73(3):938-46. doi: 10.1016/j.yrtph.2015.09.021. Epub 2015 Sep 25.

DOI:10.1016/j.yrtph.2015.09.021
PMID:26404012
Abstract

Dietary components such as lactic acid bacteria (LAB) and prebiotics can modulate the intestinal microbiota and are thought to be involved in the reduction of colorectal cancer risk. The presented study measured, using the comet assay, the antigenotoxic activity of both probiotic and non-probiotic LAB, as well as some prebiotics and the end-products of their fermentation, against fecal water (FW). The production of short chain fatty acids by the bacteria was quantified using HPLC. Seven out of the ten tested viable strains significantly decreased DNA damage induced by FW. The most effective of them were Lactobacillus mucosae 0988 and Bifidobacterium animalis ssp. lactis Bb-12, leading to a 76% and 80% decrease in genotoxicity, respectively. The end-products of fermentation of seven prebiotics by Lactobacillus casei DN 114-001 exhibited the strongest antigenotoxic activity against FW, with fermented inulin reducing genotoxicity by 75%. Among the tested bacteria, this strain produced the highest amounts of butyrate in the process of prebiotic fermentation, and especially from resistant dextrin (4.09 μM/mL). Fermented resistant dextrin improved DNA repair by 78% in cells pre-treated with 6.8 μM methylnitronitrosoguanidine (MNNG). Fermented inulin induced stronger DNA repair in cells pre-treated with mutagens (FW, 25 μM hydrogen peroxide, or MNNG) than non-fermented inulin, and the efficiency of DNA repair after 120 min of incubation decreased by 71%, 50% and 70%, respectively. The different degrees of genotoxicity inhibition observed for the various combinations of bacteria and prebiotics suggest that this effect may be attributable to carbohydrate type, SCFA yield, and the ratio of the end-products of prebiotic fermentation.

摘要

乳酸菌(LAB)和益生元等膳食成分可调节肠道微生物群,被认为与降低结直肠癌风险有关。本研究使用彗星试验测量了益生菌和非益生菌LAB、一些益生元及其发酵终产物对粪便水(FW)的抗遗传毒性活性。使用高效液相色谱法对细菌产生的短链脂肪酸进行定量。在所测试的10种活菌株中,有7种显著降低了FW诱导的DNA损伤。其中最有效的是黏液乳杆菌0988和动物双歧杆菌乳亚种Bb-12,分别使遗传毒性降低了76%和80%。干酪乳杆菌DN 114-001对7种益生元的发酵终产物对FW表现出最强的抗遗传毒性活性,发酵菊粉使遗传毒性降低了75%。在所测试的细菌中,该菌株在益生元发酵过程中产生的丁酸盐量最高,尤其是来自抗性糊精(4.09μM/mL)。发酵抗性糊精使经6.8μM甲基亚硝基胍(MNNG)预处理的细胞中的DNA修复提高了78%。与未发酵菊粉相比,发酵菊粉在用诱变剂(FW、25μM过氧化氢或MNNG)预处理的细胞中诱导更强的DNA修复,孵育120分钟后DNA修复效率分别降低了71%、50%和70%。对细菌和益生元的各种组合观察到的不同程度的遗传毒性抑制表明,这种效应可能归因于碳水化合物类型、短链脂肪酸产量以及益生元发酵终产物的比例。

相似文献

1
Antigenotoxic activity of lactic acid bacteria, prebiotics, and products of their fermentation against selected mutagens.乳酸菌、益生元及其发酵产物对特定诱变剂的抗遗传毒性活性。
Regul Toxicol Pharmacol. 2015 Dec;73(3):938-46. doi: 10.1016/j.yrtph.2015.09.021. Epub 2015 Sep 25.
2
Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.长双歧杆菌 IPLA E44 和动物双歧杆菌亚种。乳双歧杆菌 IPLA R1 产生的胞外多糖改变了 pH 控制批次培养中人体粪便微生物群的组成和代谢活性。
Int J Food Microbiol. 2009 Nov 15;135(3):260-7. doi: 10.1016/j.ijfoodmicro.2009.08.017. Epub 2009 Aug 19.
3
Effect of different prebiotics on the fermentation kinetics, probiotic survival and fatty acids profiles in nonfat symbiotic fermented milk.不同益生元对脱脂共生发酵乳发酵动力学、益生菌存活率及脂肪酸谱的影响
Int J Food Microbiol. 2009 Jan 15;128(3):467-72. doi: 10.1016/j.ijfoodmicro.2008.10.012. Epub 2008 Oct 20.
4
Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells.益生菌和益生元对人结肠腺癌细胞中粪便水诱导的DNA损伤的抗遗传毒性作用
Mutat Res. 2004 Jul 13;551(1-2):233-43. doi: 10.1016/j.mrfmmm.2004.03.010.
5
The effects of probiotics and prebiotics on the fatty acid profile and conjugated linoleic acid content of fermented cow milk.益生菌和益生元对发酵牛奶脂肪酸谱及共轭亚油酸含量的影响。
Int J Food Sci Nutr. 2015 May;66(3):254-9. doi: 10.3109/09637486.2014.992005. Epub 2015 Feb 6.
6
The influence of selected prebiotics on the growth of lactic acid bacteria for bio-yoghurt production.所选益生元对用于生物酸奶生产的乳酸菌生长的影响。
Acta Sci Pol Technol Aliment. 2011 Oct-Dec;10(4):455-66.
7
Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women.菊粉型果聚糖可调节肥胖女性肠道双歧杆菌种群并降低粪便短链脂肪酸水平。
Clin Nutr. 2015 Jun;34(3):501-7. doi: 10.1016/j.clnu.2014.06.001. Epub 2014 Jun 11.
8
The citric acid-modified, enzyme-resistant dextrin from potato starch as a potential prebiotic.来自马铃薯淀粉的柠檬酸改性、抗酶解糊精作为一种潜在的益生元。
Acta Biochim Pol. 2013;60(4):671-5.
9
Effects of non-fermented and fermented soybean milk intake on faecal microbiota and faecal metabolites in humans.非发酵和发酵豆浆摄入对人体粪便微生物群和粪便代谢物的影响。
Int J Food Sci Nutr. 2012 Jun;63(4):402-10. doi: 10.3109/09637486.2011.630992. Epub 2011 Nov 1.
10
Use of lactulose as prebiotic and its influence on the growth, acidification profile and viable counts of different probiotics in fermented skim milk.在发酵脱脂乳中使用乳果糖作为益生元及其对不同益生菌的生长、酸化特性和活菌数的影响。
Int J Food Microbiol. 2011 Jan 31;145(1):22-7. doi: 10.1016/j.ijfoodmicro.2010.11.011. Epub 2010 Nov 13.

引用本文的文献

1
Probiotics in colorectal cancer prevention and therapy: mechanisms, benefits, and challenges.益生菌在结直肠癌预防和治疗中的作用:机制、益处与挑战
Discov Oncol. 2025 Mar 26;16(1):406. doi: 10.1007/s12672-025-01996-4.
2
Antigenotoxicity and Cytotoxic Potentials of Cell-Free Supernatants Derived from Saccharomyces cerevisiae var. boulardii on HT-29 Human Colon Cancer Cell Lines.酿酒酵母 var. boulardii 无细胞上清液对 HT-29 人结肠癌细胞系的抗基因毒性和细胞毒性潜力。
Probiotics Antimicrob Proteins. 2023 Dec;15(6):1583-1595. doi: 10.1007/s12602-022-10039-1. Epub 2023 Jan 2.
3
Genoprotective activity of the mushrooms following their and fermentation by fecal microbiota.
蘑菇经粪便微生物群培养和发酵后的基因保护活性。
Front Nutr. 2022 Aug 23;9:988517. doi: 10.3389/fnut.2022.988517. eCollection 2022.
4
Immunomodulating Activity of Mushrooms Following Their In Vitro Fermentation by Human Fecal Microbiota.人粪便微生物群对蘑菇进行体外发酵后的免疫调节活性
J Fungi (Basel). 2022 Mar 22;8(4):329. doi: 10.3390/jof8040329.
5
Anticancer Potential of Post-Fermentation Media and Cell Extracts of Probiotic Strains: An In Vitro Study.益生菌菌株发酵后培养基及细胞提取物的抗癌潜力:一项体外研究。
Cancers (Basel). 2022 Apr 6;14(7):1853. doi: 10.3390/cancers14071853.
6
Molecular structure features and lactic acid fermentation behaviors of water- and alkali-soluble polysaccharides from .来自……的水溶性和碱溶性多糖的分子结构特征及乳酸发酵行为
J Food Sci Technol. 2021 Feb;58(2):532-540. doi: 10.1007/s13197-020-04564-6. Epub 2020 Jun 8.
7
Genoprotective Properties and Metabolites of β-Glucan-Rich Edible Mushrooms Following Their In Vitro Fermentation by Human Faecal Microbiota.富含β-葡聚糖的食用菌经人粪便微生物群体外发酵后的基因保护特性及代谢产物
Molecules. 2020 Aug 4;25(15):3554. doi: 10.3390/molecules25153554.
8
L. Juice Phenolic Compounds Influence Osteogenic Differentiation in Human Osteosarcoma Saos-2 Cells.L. 果汁中的酚类化合物影响人骨肉瘤 Saos-2 细胞的成骨分化。
Int J Mol Sci. 2020 Jul 11;21(14):4909. doi: 10.3390/ijms21144909.
9
Probiotic antigenotoxic activity as a DNA bioprotective tool: a minireview with focus on endocrine disruptors.益生菌的抗原毒性活性作为一种 DNA 生物保护工具:一篇关注内分泌干扰物的小型综述。
FEMS Microbiol Lett. 2020 Feb 1;367(3). doi: 10.1093/femsle/fnaa041.
10
Protective effect of the "food-microorganism-SCFAs" axis on colorectal cancer: from basic research to practical application.“食物-微生物-SCFA”轴对结直肠癌的保护作用:从基础研究到实际应用。
J Cancer Res Clin Oncol. 2019 Sep;145(9):2169-2197. doi: 10.1007/s00432-019-02997-x. Epub 2019 Aug 10.